{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:44:53Z","timestamp":1776822293631,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.urolonc.2018.02.009","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T19:48:11Z","timestamp":1521402491000},"page":"306.e9-306.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Upper tract urothelial carcinoma following intravesical bacillus Calmette-Gu\u00e9rin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study"],"prefix":"10.1016","volume":"36","author":[{"given":"Naotaka","family":"Nishiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yanase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Tachiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriomi","family":"Miyao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Kunishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Masumori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2018.02.009_bib1","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1200\/JCO.2006.08.5431","article-title":"Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments","volume":"24","author":"Parekh","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10147-006-0552-y","article-title":"Early bladder cancer: concept, diagnosis, and management","volume":"11","author":"Kitamura","year":"2006","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03008880802325226","article-title":"Bladder cancer: clinical and pathological profile","volume":"218","author":"Lopez-Beltran","year":"2008","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.urolonc.2018.02.009_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib5","unstructured":"NCCN Clinical Practice Guidelines in Oncology, https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bladder.pdf; 2017 [accessed 27 October 2017]"},{"key":"10.1016\/j.urolonc.2018.02.009_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2009.11.023","article-title":"The role of bacillus Calmette-Guerin in the treatment of non-muscle-invasive bladder cancer","volume":"57","author":"Gontero","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.urology.2005.08.066","article-title":"Management of stage T1 tumors of the bladder: International Consensus Panel","volume":"66","author":"Nieder","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.02.009_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-5347(17)43123-5","article-title":"Ureteral carcinoma\u00a0in situ after successful intravesical therapy for superficial bladder tumors: incidence, possible pathogenesis and management","volume":"138","author":"Herr","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.urolonc.2009.06.003","article-title":"Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance","volume":"29","author":"Az\u00e9mar","year":"2011","journal-title":"Urol Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2018.02.009_bib10","doi-asserted-by":"crossref","first-page":"e96467","DOI":"10.1371\/journal.pone.0096467","article-title":"A retrospective analysis of incidence and its associated risk factors of upper urinary tractrecurrence following radical cystectomy for bladder cancer with transitional cell carcinoma: the significance of local pelvic recurrence and positive lymph node","volume":"5","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2018.02.009_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1442-2042.2011.02916.x","article-title":"Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors","volume":"19","author":"Takayanagi","year":"2012","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib12","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0022-5347(05)67137-6","article-title":"Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups","volume":"164","author":"Mill\u00e1n-Rodr\u00edguez","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1200\/JCO.2001.19.1.94","article-title":"Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance","volume":"19","author":"Rabbani","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0090-4295(99)00116-8","article-title":"Intravesical bacille Calmette-Gu\u00e9rin in stage T1 grade 3 bladder cancer therapy: a 7-year follow-up","volume":"54","author":"Hurle","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.02.009_bib15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0090-4295(99)00002-3","article-title":"Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients","volume":"53","author":"Hurle","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.02.009_bib16","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.juro.2012.08.017","article-title":"Upper urinary tract\u00a0recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients","volume":"188","author":"Picozzi","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.1998.16.3.1099","article-title":"Extravesical tumor relapse in patients with superficial bladder tumors","volume":"16","author":"Herr","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/jjco\/hyu119","article-title":"Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: results from a multicenter retrospective study","volume":"44","author":"Nishiyama","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1464-410X.2010.09830.x","article-title":"Radical cystectomy for BCG failure: has the timing improved in recent years?","volume":"108","author":"Soloway","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.02.009_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-5347(01)62065-2","article-title":"Urinary interleukin-2 monitoring during prolonged bacillus Calmette-Guerin treatment: can it predict the optimal number of instillations?","volume":"161","author":"de Reijke","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0090-4295(93)90329-9","article-title":"Upper tract transitional cell carcinoma following treatment of superficial bladder cancer with BCG","volume":"42","author":"Miller","year":"1993","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.02.009_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2011.11.011","article-title":"Should follow-up cystoscopy in bacillus Calmette-Gu\u00e9rin-treated patients continue after five tumour-free years?","volume":"61","author":"Holm\u00e4ng","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib23","article-title":"Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A","author":"Inokuchi","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib24","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1111\/j.1464-410X.2011.10188.x","article-title":"Racial differences in the outcome of patients with urothelial carcinoma of the\u00a0upper urinary tract: an international study","volume":"108","author":"Matsumoto","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.02.009_bib25","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.urolonc.2012.03.004","article-title":"Prognostic significance of non-muscle-invasive bladder tumor history in patients with\u00a0upper urinary tract\u00a0urothelial carcinoma","volume":"31","author":"Milojevic","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1464-410x.2000.00344.x","article-title":"A clinicopathological study of bladder cancer associated with upper urinary tract\u00a0cancer","volume":"85","author":"Miyake","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.02.009_bib27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.ju.0000169424.79702.6d","article-title":"Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and\u00a0upper urinary tract\u00a0tumor","volume":"174","author":"Palou","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-5347(17)49028-8","article-title":"Upper urinary tract\u00a0transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux","volume":"133","author":"Amar","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrurol.2011.96","article-title":"Prognostic factors for\u00a0upper urinary tract\u00a0urothelial carcinoma","volume":"8","author":"Chromecki","year":"2011","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2018.02.009_bib30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1464-410X.2011.10462.x","article-title":"Prognostic factors and outcome in patients with T1 high-grade\u00a0bladder cancer: can we identify patients for early cystectomy?","volume":"109","author":"Segal","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.02.009_bib31","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.juro.2016.11.094","article-title":"A multi-institutional comparison of clinicopathological characteristics and oncologic outcomes of upper tract urothelial carcinoma in China and the United States","volume":"197","author":"Singla","year":"2017","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143918300656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143918300656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:12:43Z","timestamp":1761041563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143918300656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1078143918300656"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.02.009","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upper tract urothelial carcinoma following intravesical bacillus Calmette-Gu\u00e9rin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}